Sandoz Tacrolimus 5 mg

SANDOZ TACROLIMUS 5 MG capsules are an immunosuppressant medication used to prevent organ rejection after transplants. This oral formulation is designed for immediate release and is manufactured by SANDOZ Canada Incorporated.

TACROLIMUS (TACROLIMUS MONOHYDRATE) is primarily used to prevent the body from rejecting transplanted organs. It works by suppressing the immune system to reduce the risk of organ rejection. This medication is often prescribed for patients who have undergone liver, kidney, or heart transplants. It may also be used in other conditions where immune system suppression is necessary.

Common effects of TACROLIMUS 5 MG capsules may include headaches, tremors, and gastrointestinal issues such as nausea or diarrhea. Some users may experience increased blood pressure or changes in kidney function. It is important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

TACROLIMUS should be handled with care, as it is a potent immunosuppressant. It is crucial to follow the prescribed dosage and administration instructions. Avoid grapefruit and grapefruit juice, as they can interact with the medication. Regular blood tests may be required to monitor kidney function and drug levels.

TACROLIMUS can interact with various medications, including other immunosuppressants, antifungal agents, and certain antibiotics. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol should be avoided as it may exacerbate side effects.